Eptifibatide

Brevis descriptio:


  • Product nomen:Eptifibatide
  • Cas No:148031-34-9
  • Formulae hypotheticae:C35H49N11O9S2
  • Pondus hypotheticum:831.97 g/mol
  • SEQUENTIA:3-mercaptopropionyl-homoarg-gly asp-pro cys-nh2 sal acetatis
  • ADVENTUS:Pulvis albus
  • APPLICANDIS:Eptifibatide est a Platelet aggregatio Inhibitor. Tractus de angina pectoris instabilis, infarctio myocardialis acuti
  • FASCICULUS:Secundum Lorem scriptor requisitis
  • Product Detail

    Product Tags

    DESCRIPTIO

    Eptifibatideest heptapeptida cyclica continens 6 amino acida et 1 mercaptopropionyl (des-amino cysteinyl) residuum. Interchain disulfidorum pons inter cysteinum inter et mercaptopropionyl medietatem constituitur. Chemice est N6- (aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-Llysylglycyl-L- α-aspartyl-L- tryptophyl-L-prolyl-L-cysteinamideum, cyclicum (1 →6)-disulfide. Eptifibatide ligat ad receptatorem glycoprotein in platelet (GP) IIb/IIIa laminarum humanarum et aggregationem in laminam vetat.

    Keywords

    • Eptifibatide acetatis
    • peptide
    • CAS#148031-34-9

    Velox Details

    • ProName: Eptifibatide
    • CasNo: 148031-34-9
    • Formulae hypotheticae: C35H49N11O9S2
    • Aspectus: cerussa
    • Applicatio: Coronarius percutaneous non urgens inter…
    • DeliveryTime: promptum sit amet
    • Sarcina: secundum necessitates
    • Portus: shenzhen
    • ProductionCapacity: V Kilogram/mense
    • Puritas: 98%
    • Repono: II ~ VIII, custodita a lumine
    • Transportatio: per aerem
    • LimitNum: 1 Gram

    Superioritas

    professional peptide fabrica in Sina.
    princeps qualis est gmp gradus
    magnis auctoribus pretium
    nostra producta complectitur: mole generica apis peptidis, peptide medicatura, consuetudo peptides et peptides veterinarii.

    hypothetica formula

    c35h49n11o9s2

    secundum hypotheticam molem

    831.97 g/mol

    longum tempus repono:

    -20 ± 5°c

    series:

    3-mercaptopropionyl-homoarg-gly asp-pro cys-nh2 sal acetatis

     

    Singula

    Societas Profile:
    societas nomen:Shenzhen JYMed Technologia Co.,Ltd.
    Annus Constitutus: 2009
    Capital: 89.5 Million RMB
    Acetatum oxytocinum, acetatis vasopressinum, acetatis Desmopressin, acetatis terlipressin, acetatis Caspofungin, micafungin sodium, acetatis eptifibatidis, acetatis bivalirudin TFA, Deslorelini acetatis, acetatis glucagonis, acetatis histrelini, acetatis Caspofunginin, aceta- tis aeteris, acetatis elixatae, acetatis Bivalirudin TFA, deslorelin acetatis, glucagon. Acetate, Goserelin
    Acetate, Argireline Acetate, Metrixyl Acetate, Snap VIII, ....
    Studemus continuas innovationes in nova synthesi technologiae peptide et processu optimizationis, et nostra turma technica supra decennium experientiae in synthesi peptide.JYM feliciter multum submisit.
    of ANDA peptide APIs et producta cum CFDA formata et supra quattuor patentes approbatas habent.
    Nostra planta peptide in Nanjing sita, provincia Jiangsu et facilitatem 30,000 metrorum quadratorum posuit in obsequio cum indice cGMP. Facilitas artificiorum ab clientibus tam domesticis quam internationalibus est audita et inspecta.
    Cum praestantissima qualitate, pretiosissima et validissima subsidia technica, JYM recognitiones non solum acquisivit pro suis Institutis Investigationis et industriarum pharmaceuticae, sed etiam unus factus est ex certissimis praebitoribus peptidum in Sinis. JYM dedicatum est unum esse provisor primarius peptidis mundi in proximo futuro.

     








  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis